Results 101 to 110 of about 16,917 (221)
Background: The COVID-19 pandemic which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a major global health crisis in recent years.
Vidya Chikkarahalli Srikantaiah +8 more
doaj +1 more source
Drug-related Dysgeusia: A Systematic Review.
Dysgeusia is an unpleasant alteration in taste. It can affect the nutritional and psychological status and decrease the quality of life of patients. It may be caused by nerve injury, head and neck trauma or surgery, infections, radiotherapy and drugs, but certain aetiological factors have not yet been identified.
Hamed, Mortazavi +3 more
openaire +2 more sources
Fluorescence imaging enables the detection of subclinical actinic cheilitis by revealing early optical alterations in lip tissue. Methylene blue‐mediated photodynamic therapy selectively targets dysplastic areas, enhancing treatment precision and preventing disease progression without adverse effects.
Juliana Cristina Oliverio de Araújo +4 more
wiley +1 more source
Oral Medicine Under Review: Current Practices and Future Pathways for Specialty Recognition
Oral Diseases, EarlyView.
N. G. Nikitakis +14 more
wiley +1 more source
Earlier variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), including the original strain, Alpha and Delta, were linked to significant and persistent cognitive impairment. The long‐term cognitive impact of Omicron infection, however, has remained uncertain. This study shows that post‐Omicron cognitive decline is largely reversible,
Min Qiu +15 more
wiley +1 more source
Zinc Gluconate in the Treatment of Dysgeusia—a Randomized Clinical Trial [PDF]
In the treatment of dysgeusia, the use of zinc has been frequently tried, with equivocal results. The aim of the present randomized clinical trial, which involved a sufficiently large sample, was therefore to determine the efficacy of zinc treatment ...
Heckmann, Siegfried Martin +6 more
core
Objective: To describe the prevalence, onset, associated symptoms, and clinical characteristics of COVID-19 in-patients with olfactory and gustatory dysfunction at the Philippine General Hospital from March 2021 to January 2022 and determine the number ...
Chantel Jacqueline Tirol +1 more
doaj +1 more source
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder
A case series studying outcomes up to 18 months in autistic patients from the UK Medical Cannabis Registry. ABSTRACT Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder associated with distressed behaviors and psychological challenges.
Arushika Aggarwal +17 more
wiley +1 more source
Factors associated with loss and recovery of smell and taste after COVID‐19 infection
Objective To identify predictors associated with loss and recovery of smell and taste after COVID‐19 infection. Methods The Integrated Public Use Microdata Series (IPUMS) 2021 National Health Interview Series (NHIS) database was used to analyze factors ...
Diego E. Razura +3 more
doaj +1 more source
Background: Dysgeusia is a frequent side effect in breast cancer patients undergoing adjuvant chemotherapy. The effect of dysgeusia on changes in diet and patient weight has been poorly investigated.
G Schivardi +12 more
core +1 more source

